LIVE-ENOX Investigators Efficacy and safety of two doses of enoxaparin in women with thrombophilia and recurrent pregnancy loss: The LIVE-ENOX study
Brenner B, Hoffman R, Carp H, Dulitsky M, Younis J; LIVE-ENOX Investigators. Efficacy and safety of two doses of enoxaparin in women with thrombophilia and recurrent pregnancy loss: the LIVE-ENOX study. J Thromb Haemost. 2005; 3:227-229.
Low-molecular weight heparin versus lowdose aspirin in women with one fetal loss and a constitutional thrombophilic disorder
Gris JC, Mercier E, Quere I, et al. Low-molecular weight heparin versus lowdose aspirin in women with one fetal loss and a constitutional thrombophilic disorder. Blood. 2004;103:3695-3699.
A randomized study of thromboprophylaxis in women with unexplained consecutive recurrent miscarriages
Dolitzky M, Inbal A, Segal Y, Weiss A, Brenner B, Carp H. A randomized study of thromboprophylaxis in women with unexplained consecutive recurrent miscarriages. Fertil Steril. 2006;86:362-366.
Aspirin plus heparin or aspirin alone in women with recurrent miscarriage
Kaandorp SP, Goddijn M, van der Post JA, et al. Aspirin plus heparin or aspirin alone in women with recurrent miscarriage. N Engl J Med. 2010;362:1586-1596.
SPIN (Scottish Pregnancy Intervention) study: A multicenter, randomized controlled trial of low-molecular-weight heparin and low-dose aspirin in women with recurrent miscarriage
Clark P, Walker ID, Langhorne P, et al. SPIN (Scottish Pregnancy Intervention) study: a multicenter, randomized controlled trial of low-molecular-weight heparin and low-dose aspirin in women with recurrent miscarriage. Blood. 2010;115: 4162-4167.